List of Excipients in API glimepiride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing glimepiride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | CELLULOSE, MICROCRYSTALLINE | |
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | FERRIC OXIDE RED | |
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | LACTOSE | |
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | MAGNESIUM STEARATE | |
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | POVIDONE | |
| Sanofi-Aventis US LLC | AMARYL | glimepiride | 0039-0221 | SODIUM STARCH GLYCOLATE TYPE A CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing glimepiride
Detailed excipient profiles for glimepiride
Excipient focus: ALUMINUM OXIDE
glimepiride drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | glimepiride | 66116-432 |
| >Company | >Ingredient | >NDC |
glimepiride drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
glimepiride drug variants containing CELLULOSE, MICROCRYSTALLINE
glimepiride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C YELLOW NO. 10
glimepiride drug variants containing D&C YELLOW NO. 10
glimepiride drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
glimepiride drug variants containing FD&C BLUE NO. 1
glimepiride drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
glimepiride drug variants containing FD&C BLUE NO. 2
glimepiride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
glimepiride drug variants containing FERRIC OXIDE RED
glimepiride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
glimepiride drug variants containing FERRIC OXIDE YELLOW
glimepiride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: INDIGOTINDISULFONATE SODIUM
glimepiride drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| QPharma Inc | glimepiride | 42708-083 |
| >Company | >Ingredient | >NDC |
glimepiride drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: LACTOSE
glimepiride drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | glimepiride | 0039-0221 |
| >Company | >Ingredient | >NDC |
glimepiride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
glimepiride drug variants containing LACTOSE MONOHYDRATE
glimepiride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | glimepiride | 0039-0221 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
glimepiride drug variants containing MAGNESIUM STEARATE
glimepiride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
glimepiride drug variants containing POLOXAMER 188
glimepiride drug variants not containing POLOXAMER 188
Excipient focus: POLYSORBATE 80
glimepiride drug variants containing POLYSORBATE 80
glimepiride drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
glimepiride drug variants containing POVIDONE
glimepiride drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
glimepiride drug variants containing POVIDONE K25
glimepiride drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K30
glimepiride drug variants containing POVIDONE K30
glimepiride drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
glimepiride drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | glimepiride | 0615-7523 |
| Aidarex Pharmaceuticals LLC | glimepiride | 33261-892 |
| Northwind Pharmaceuticals | glimepiride | 51655-381 |
| DirectRX | glimepiride | 61919-720 |
| >Company | >Ingredient | >NDC |
glimepiride drug variants not containing POVIDONES
Excipient focus: SODIUM LAURYL SULFATE
glimepiride drug variants containing SODIUM LAURYL SULFATE
glimepiride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
glimepiride drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | glimepiride | 0039-0221 |
| >Company | >Ingredient | >NDC |
glimepiride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
glimepiride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
glimepiride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
